PubRank

Lukasz Kedzierski

Author PubWeight™ 13.80‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Cross-reactive CD8+ T-cell immunity between the pandemic H1N1-2009 and H1N1-1918 influenza A viruses. Proc Natl Acad Sci U S A 2010 1.63
2 The SPRY domain-containing SOCS box protein SPSB2 targets iNOS for proteasomal degradation. J Cell Biol 2010 1.14
3 Development of Vaccines against Visceral Leishmaniasis. J Trop Med 2011 1.03
4 Fine mapping of Leishmania major susceptibility Locus lmr2 and evidence of a role for Fli1 in disease and wound healing. Infect Immun 2010 1.00
5 Oral immunization with a recombinant malaria protein induces conformational antibodies and protects mice against lethal malaria. Infect Immun 2003 0.92
6 Recent advances in antileishmanial drug development. Curr Opin Investig Drugs 2005 0.92
7 Inhibitors of Leishmania GDP-mannose pyrophosphorylase identified by high-throughput screening of small-molecule chemical library. Antimicrob Agents Chemother 2010 0.85
8 Induction of protective CD4+ T cell-mediated immunity by a Leishmania peptide delivered in recombinant influenza viruses. PLoS One 2012 0.85
9 Suppressor of Cytokine Signaling (SOCS) 5 utilises distinct domains for regulation of JAK1 and interaction with the adaptor protein Shc-1. PLoS One 2013 0.85
10 Anti-Leishmanial activity of homo- and heteroleptic bismuth(III) carboxylates. J Inorg Biochem 2010 0.85
11 Influence of glycosylphosphatidylinositol anchorage on the efficacy of DNA vaccines encoding Plasmodium yoelii merozoite surface protein 4/5. Vaccine 2005 0.79
12 Diversity and clonotypic composition of influenza-specific CD8+ TCR repertoires remain unaltered in the absence of Aire. Eur J Immunol 2010 0.78
13 Bismuth(III) β-thioxoketonates as antibiotics against Helicobacter pylori and as anti-leishmanial agents. Dalton Trans 2013 0.78
14 Fishing for anti-leishmania drugs: principles and problems. Adv Exp Med Biol 2008 0.77
15 Discovery of inhibitors of lupin diadenosine 5',5'''-P(1),P(4)-tetraphosphate hydrolase by virtual screening. Biochemistry 2009 0.76
16 Crystal structure of the Leishmania major MIX protein: a scaffold protein that mediates protein-protein interactions. Protein Sci 2011 0.75
17 Anti-leishmanial activity of heteroleptic organometallic Sb(v) compounds. Dalton Trans 2013 0.75
18 Stability and toxicity of heteroleptic organometallic Bi(V) complexes towards Leishmania major. Dalton Trans 2014 0.75
19 Stability and toxicity of tris-tolyl bismuth(v) dicarboxylates and their biological activity towards Leishmania major. Dalton Trans 2015 0.75
20 Augmenting influenza-specific T cell memory generation with a NKT cell-dependent glycolipid-peptide vaccine. ACS Chem Biol 2017 0.75